Separately, biotech company Alector Inc. has begun first-step patient testing of a drug designed to boost TREM2 and better activate microglia.
News
- Scientists rethink Alzheimer's, diversifying the drug search
- 5 scientists honored for cancer therapy, immune system work
The award will be shared by H. Michael Shepard and Axel Ullrich, who were with the biotech company Genentech when they did the research, and ...
- UTSA to add new degree for biomedical entrepreneurs
The University of Texas at San Antonio hopes to boost the local biomedical industry by adding a new academic degree program for biomedical ...
- GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) Reports Increase in Sellers ...
Generex Biotechnology Corporation does not have significant business ... Care (SAWC) in San Antonio, TX – Yahoo Finance” published on May 16, ...
- AT&T and Acadia post gains while Clorox and Amgen stumble
The biotechnology company reported positive results from a key study of a potential dementia-related psychosis drug. Clorox Co., down $3.71 to ...